BAAM
CGEM icon

Baker Avenue Asset Management’s Cullinan Oncology CGEM Stock Holding History

Baker Avenue Asset Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-48
Closed -$434 – 559
2023
Q3 		$434 Hold
48
– – ﹤0.01% 1509
2023
Q2 		$516 Hold
48
– – ﹤0.01% 1387
2023
Q1 		$491 Hold
48
– – ﹤0.01% 1441
2022
Q4 		$506 Buy
+48
New +$583 ﹤0.01% 1311

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Baker Avenue Asset Management's CGEM Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Cullinan Oncology (CGEM) in Q4 2023, closing a stake of 48 shares — an estimated $434 sold.

Baker Avenue Asset Management first reported a position in CGEM in Q4 2022 and held it in 4 quarters. The position peaked at $516 in Q2 2023. 113 funds tracked by Wall St. Rank hold CGEM as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Cullinan Oncology position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 48 Cullinan Oncology shares in Q4 2023, an estimated $434.
  • Baker Avenue Asset Management first reported a position in Cullinan Oncology in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's Cullinan Oncology position peaked at $516 in Q2 2023.
  • 113 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.